Role of fibroblast growth factor-23 as an early marker of metabolic bone disease of prematurity

• Main Authors: Sandra Llorente-Pelayo (Author), Pablo Docio (Author), Silvia Arriola (Author), Bernardo A. Lavín-Gómez (Author), María T. García-Unzueta (Author), María Ángeles Ballesteros (Author), María J. Cabero-Pérez (Author), Domingo González-Lamuño (Author)
• Format: Book
• Published: BMC, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Purpose Metabolic bone disease of prematurity (MBDP) remains a significant cause of morbidity in extremely premature newborns. In high-risk patients, suspected diagnosis and subsequent treatment modifications, with limitations in terms of sensitivity and specificity, rely on low phosphorus...